Literature DB >> 12790153

Aripiprazole.

Michelle A Grady1, Timothy L Gasperoni, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12790153     DOI： 10.1038/nrd1114

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 2.  Signalling bias in new drug discovery: detection, quantification and therapeutic impact.

Authors:  Terry Kenakin; Arthur Christopoulos
Journal:  Nat Rev Drug Discov       Date:  2012-02-15       Impact factor: 84.694

3.  Replacement of active-site residues of quinoline 2-oxidoreductase involved in substrate recognition and specificity.

Authors:  Vladimir Purvanov; Susanne Fetzner
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

4.  Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor.

Authors:  H Lin; S G N Saisch; P G Strange
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

5.  Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.

Authors:  Kerstin Schwabe; Michael Koch
Journal:  Psychopharmacology (Berl)       Date:  2006-09-05       Impact factor: 4.530

6.  Waterborne aripiprazole blunts the stress response in zebrafish.

Authors:  Heloísa Helena de Alcantara Barcellos; Fabiana Kalichak; João Gabriel Santos da Rosa; Thiago Acosta Oliveira; Gessi Koakoski; Renan Idalencio; Murilo Sander de Abreu; Ana Cristina Varrone Giacomini; Michele Fagundes; Cristiane Variani; Mainara Rossini; Angelo L Piato; Leonardo José Gil Barcellos
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

7.  Design, synthesis, and biological evaluation of N-arylpiperazine derivatives as interferon inducers.

Authors:  Yeonjeong Chu; B Raja Sekhara Reddy; V Pratap Reddy Gajulapalli; K Sudhakar Babu; Eunha Kim; Sanghee Lee
Journal:  Bioorg Med Chem Lett       Date:  2020-10-16       Impact factor: 2.823

Review 8.  Piperazine based antimicrobial polymers: a review.

Authors:  Manohara Dhulappa Jalageri; Akshatha Nagaraja; Yashoda Malgar Puttaiahgowda
Journal:  RSC Adv       Date:  2021-04-23       Impact factor: 3.361

Review 9.  The potential for selective pharmacological therapies through biased receptor signaling.

Authors:  Terry Kenakin
Journal:  BMC Pharmacol Toxicol       Date:  2012-08-13       Impact factor: 2.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.